CNBX Pharmaceuticals Inc (CNBX)

OTC Markets
Currency in USD
0.0006
0.0000(0.00%)
Closed·
CNBX Scorecard
Full Analysis
Operates with a significant debt burden
Trading near 52-week Low
Fair Value
Day's Range
0.00050.0007
52 wk Range
0.00050.0199
Key Statistics
Edit
Prev. Close
0.0006
Open
0.0006
Day's Range
0.0005-0.0007
52 wk Range
0.0005-0.0199
Volume
9.46M
Average Volume (3m)
8.89M
1-Year Change
-91.43%
Book Value / Share
-0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNBX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.

Compare CNBX to Peers and Sector

Metrics to compare
CNBX
Peers
Sector
Relationship
P/E Ratio
−0.4x−1.9x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x2.6x
Price / LTM Sales
-1.0x3.1x
Upside (Analyst Target)
-243.4%46.1%
Fair Value Upside
Unlock10.3%6.9%Unlock

Earnings

Latest Release
Apr 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNBX Income Statement

FAQ

What Is the CNBX Pharmaceuticals (CNBX) Stock Price Today?

The CNBX Pharmaceuticals stock price today is 0.00.

What Stock Exchange Does CNBX Pharmaceuticals Trade On?

CNBX Pharmaceuticals is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for CNBX Pharmaceuticals?

The stock symbol for CNBX Pharmaceuticals is "CNBX."

What Is the CNBX Pharmaceuticals Market Cap?

As of today, CNBX Pharmaceuticals market cap is 112.71K.

What Is CNBX Pharmaceuticals's Earnings Per Share (TTM)?

The CNBX Pharmaceuticals EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is CNBX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CNBX Pharmaceuticals Stock Split?

CNBX Pharmaceuticals has split 3 times.

How Many Employees Does CNBX Pharmaceuticals Have?

CNBX Pharmaceuticals has 1 employees.

What is the current trading status of CNBX Pharmaceuticals (CNBX)?

As of 12 Jul 2025, CNBX Pharmaceuticals (CNBX) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.